How not to detect ovarian cancer

Article

Screening with annual transvaginal ultrasound (TVU) and CA125 is ineffective at detecting early-stage ovarian cancer in both high- and low-risk women, according to the findings of a retrospective audit study involving 341 asymptomatic women.

Screening with annual transvaginal ultrasound (TVU) and CA125 is ineffective at detecting early-stage ovarian cancer in both high- and low-risk women, according to the findings of a retrospective audit study involving 341 asymptomatic women.

In breaking down the participants, 179 of the women had more than a 10% lifetime risk of developing ovarian cancer, 77 fell into a moderate risk group (4%-0% lifetime risk), and 71 had less than a 4% lifetime risk.

Thirty women underwent exploratory surgery because of abnormal findings, but only two had cancer, and only one had ovarian cancer; the other had endometrial cancer.

The researchers calculated the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for TVU in the whole cohort to be 33.3%, 85.8%, 0.6%, and 99.8%, respectively. For those at high risk, the same figures for TVU were 33.3%, 84.5%, 1.1%, and 99.6%, respectively. The values for both modalities for the entire study population were 66.7%, 82.9%, 1.5%, and 99.8%, respectively. The values for both modalities applied to the high-risk group alone were 50%, 82.8%, 1.3%, and 99.7%, respectively.

Woodward ER, Sleightholme HV, Considine AM, et al. Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective. BJOG. 2007;114:1500-1509.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Ciera Kirkpatrick, PhD, shows how TikTok is transforming cervical cancer awareness | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.